Projects

doc. Ing. Igor Beliaev, DrSc.
Head , Department of Radiobiology

International

Current
  • Genomic instability in cells from persons exposed to RF from base stations
    Program: Other
    Duration: 8. 9. 2021 – 31. 12. 2027
Finished
  • Molecular Markers for Biological Dosimetry in Radiation Oncology, Cancer Risk, Assesment and Optimizing Cancer Therapy
    Program: IAEA
    Duration: 19. 9. 2017 – 9. 7. 2023
  • Cancer diagnostics and assessment of cancer risk
    Program: Inter-academic agreement
    Duration: 1. 1. 2013 – 31. 12. 2015
  • Individual radiosensitivity of cancer patients and nuclear-chemical personnel
    Program: Inter-academic agreement
    Duration: 1. 1. 2013 – 31. 12. 2015

National

Current
  • Evaluation of 5G radiation induced genotoxicity and assessment of phytochemicals as modulator of radiation induced DNA damage and cancer
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Assessment of DNA damage and genetic instability in hospital workers occupationally exposed to low doses of ionizing radiation
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Study of genotoxic  effects from magnetic resonance imaging in human lymphocytes
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Epigenetic regulation effect of circRNA on radiation-induced damage
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2026
  • Radiation-induced noncoding RNAs in mononuclear cells of umbilical cord blood
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Strengthening of research, development and innovation capacities of translational biomedical research of human diseases
    Program:
    Duration: 1. 1. 2020 – 30. 6. 2023
  • Mechanisms of impact of low intensity electromagnetic radiation on course of cancer disease
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Radiation-induced preleukemic fusion genes in proliferating hematopoietic stem/progenitor cells of umbilical cord blood
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Biomarkers for assessment of individual radiosensitivity in breast cancer therapy
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • DNA damage REsponse and preleukemic Clones in hematopoietic stem cells in diagnOstics, Risk estimation and treatment of peDiatric leukemia
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 9. 2019
  • Constitutive and induced DNA damage in hematopoietic cells for assessment of risk and optimizing treatment of childhood leukemia
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Preleukemic gene fusions and DNA repair in umbilical cord blood cells
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • In vitro research on RF-EMF induced DNA alterations in three cell types
    Program:
    Duration: 3. 8. 2011 – 30. 12. 2015
  • Molecular markers of DNA repair in cancer therapy
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • DNA repair and preleukemic clones in cord blood stem cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Implementation of radiobiological research of intensity-modulated proton therapy into clinical oncology practice
    Program: EU Structural Funds Research & Development
    Duration: 20. 10. 2010 – 31. 3. 2014
  • Molecular markers for prediction of individual radiosensitivity in cancer therapy
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
Employees